Harmony Biosciences Holdings, Inc.HRMYNASDAQ
Loading
Operating Cash Flow Growth Recovery in ProgressRecovering
Percentile Rank71
3Y CAGR+7.8%
5Y CAGR-9.5%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
+7.8%/yr
Annual compound
5Y CAGR
-9.5%/yr
Recent acceleration
Percentile
P71
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 58.40% |
| 2024 | 0.20% |
| 2023 | 51.86% |
| 2022 | 46.58% |
| 2021 | 3401.74% |
| 2020 | 96.04% |
| 2019 | -94.43% |
| 2018 | 0.00% |